Access to antibiotics in the Nordic region, final version
Monday 25 November 2024
|
|
||
|
10.00 |
Introduction |
Katarina Lönnquist Moderator
Swedish Medical Products Agency |
|
10:10 |
Welcome |
Petra Noreback
Secretary of State
Ministry of Social Affairs
Joakim Brandberg
Acting Director General,
Swedish Medical Products Agency
Jenny Pentler,
Senior Advisor,
Nordic Council of Ministers. |
|
MENTIMETER |
||
|
10.30 |
Outcome from the high-level meeting on AMR in UNGA 2024 |
Malin Grape Ambassador on Antimicrobial resistence Sweden |
|
10.45 |
Ensuring global access to effective antibiotics Global access to antibiotics to counteract development of AMR |
Otto Cars Professor emeritus Uppsala University |
|
11.00 |
One Health An integrated, unifying approach to balance and optimize the health of people, animals and environment |
Susanna Sternberg Lewerin Professor Swedish University of Agricultural Science |
|
11.15 |
Nordic AMR initiatives Initiatives in the Nordic region within human, veterinary and environmental sector |
Marmar Nekoro Assessor Swedish Medical Products Agency |
|
11.30 |
Survey of the antibiotic market in the Nordic region An overview of all formulations, strengths, and packages of registered antibiotics for human use in the Nordic region |
Anders Ternhag Clinical Assessor Public Health Agency of Sweden |
|
11.45 |
Supply chain transparency Supply chain transparency and improved information sharing about supply and needs are factors that could improve access to antibiotics for both human and animals |
Enrico Baraldi Professor Uppsala University, PLATINEA |
|
12.00 |
LUNCH |
|
|
13.00 |
Digital Minerva-system To keep track of the availability of critical medicinec, including antibiotics, across Denmark |
Lars Dmowski Rugholm Senior advisor Danish Medicines Agency |
|
13.15 |
Mapping of production capacity Mapping of production capacity - a Swedish Government Assignment |
Ulrika Espefält Westin Project Manager Swedish Medical Products Agency |
|
13.30 |
Withdraw or keep antibiotics on the Nordic market? Reasons behind strategic decisions from the industry whether to keep or withdraw antibiotics from the Nordic market |
Adam Estrup Chief Executive Officer, ViNordic - Veterinay Industry Nordic |
|
13.45 |
Shortages - industry perspective Presentation from the industry perspective of shortages and access of antibiotics |
Bengt Mattson Policy manager LIF- Trade association for the research based pharmaceutical industry |
|
|
MENTIMETER |
|
|
14.05 |
Nordic procurement initiative with environment incentives for the industry Ongoing Nordic procurement initiative with environmental incentives for antibiotics |
Gudrun Gudnadottir Expert procurement Sykehusinnkjøp HF |
|
14.20 |
Reimbursement model Outcome of reimbursement model and ongoing initiative to implement a model in the Nordic region to ensure future access to antibiotics |
Jenny Hellman Head of Unit Public Health Agency of Sweden |
|
14.35 |
Access to antibiotics Challenges from a manufacturer’s perspective |
Kenneth Nyblom CEO FGL - The Association for Generic Pharmaceuticals and Biosimilars in Sweden |
|
14.50 |
PHOTO |
|
|
15.00 |
COFFEE |
|
|
15.30 |
Managing AMR in the environment while maintaining access to antibiotics Examples related to antibiotic pollution from both manufacturing and use |
Joakim Larsson Professor Gothenburg University, Director of Centre for Antibiotic Resistance Research, CARe |
|
15.45 |
Environmental premium within the Swedish pharmaceutical benefits system Ongoing government assignment to incentivise environmental responsibility in production of pharmaceuticals |
Krister Halldin Environmental and sustainability assessor Swedish Medical Products Agency |
|
16.00 |
Treatment recommendations - Healthcare perspective Impact of updated treatment recommendations from a healthcare perspective as well as an overview of the ongoing initiatives and collaboration |
Thomas Tängdén, President STRAMA - National working model to address antibiotic resistance in health care |
|
16.15 |
Nordic common packaging Possibility to register Nordic packaging to reduced regulatory administration. Relevant for both human and veterinary antibiotics |
Cecilia Ulleryd Head of unit Swedish Medical Products Agency |
|
16.30 |
MRP - Fast track for antibiotics? Possibility to use Zero-day Mutual Recognition Procedure (MRP) when registrating antibiotics in the Nordic region |
Helena Malm Regulatory assessor Swedish Medical Products Agency |
|
16.45 |
Closure |
|
|
17.30 |
Busses leave for museum and dinner |
|
Access to antibiotics in the Nordic region
Tuesday 26 November 2024
|
|
||
|
09.00 |
Workshops |
1-8 |
|
10.00 |
COFFE |
|
|
10.30 |
Workshops |
1-8 |
|
11.30 |
JAMRAI-2 Ongoing European project with the objective to increase access to antibiotics for humans and animals |
Christine Årdal Senior Researcher Norwegian Institute of Public Health |
|
11.45 |
Access to antibiotics in Iceland |
Olöf Thorhallsdottir Head of section Icelandic Medicines Agency |
|
12.00 |
LUNCH |
|
|
13.00 |
Challenges with clinical trials when developing new antibiotics |
Gunilla Andrew Nielsen Head of Unit Swedish Medical Products Agency |
|
13.15 |
Funding research and development Comparative study on pull incentives for antibiotics R&D |
Carl Björvang Assessor Swedish Dental and Pharmaceutical Benefits Agency |
|
13.30 |
Antibiotics in pipeline |
Anders Karlén Professor Uppsala University |
|
|
MENTIMETER |
|
|
13.50 |
AMR in legislations Legislation from different sectors counteract AMR |
Åsa Kumlin Howell Head of International Affairs Swedish Medical Products Agency |
|
14.05 |
Rapid diagnostics for optimized use of antibiotics and preservation of future efficacy
|
Petter Knagge Director Research Sysmex Astrego |
|
14.20 |
Vaccines and bacterial infections in animals |
Johanna Lindahl Head of section Swedish Veterinary Agency |
|
14.35 |
Treatment recommendations - Veterinary perspective Importance of updated treatment recommendations for veterinaries and the consequence of shortages |
Katariina Kivilahti-Mäntylä Veterinary officer Finnish Medicines Agency |
|
14.50 |
COFFEE |
|
|
15.15 |
Think Tank Reflections from this conference to the future Nordic collaboration against AMR
Moderator: Thomas Ekelund Swedish Medical Products Agency |
Lina Pastorek Swedish Ministry of Social Affairs Sweden Christine Årdal Norwegian Institute of Public Health Norway Adam Estrup ViNordic Denmark Ólöf Þórhallsdóttir
Icelandic Medicines Agency Iceland Tita-Maria Muhonen FinnishMedicines Agency Finland |
|
|
MENTIMETER |
|
| 15.45 | Summary |
My Moberg Director Swedish Medical Products Agency |
|
15.55 |
Closure |
Katarina Lönnquist Moderator Swedish Medical Products Agency |
|
|
|
|